Cyclical Cushing's disease and its successful control under sodium valproate
- PMID: 2090672
- DOI: 10.1007/BF03349657
Cyclical Cushing's disease and its successful control under sodium valproate
Abstract
Several subgroups of Cushing's disease were recently described (anterior or intermediate lobe origin, hyper-or hypo-pulsatility of cortisol, presence or absence of response after GRH or TRH, cyclical Cushing's disease). We present here a detailed case report on a patient suffering from Cushing's disease whose endocrine functions were extensively investigated. Treatment with bromocriptine, as well as subsequent transsphenoidal surgery, were followed by rapid but transient reversal of symptoms. When clinical manifestations reoccurred, daily measurements of free urinary cortisol revealed a cyclic pattern of cortisol hyperexcretion. A study of ultradian rhythm revealed hyperpulsatility of cortisol secretion. More interestingly, a treatment with sodium valproate, a drug known to inhibit CRH production, was followed by a rapid and longstanding normalization of clinical and biological data for 2 years. Based on these data, and on information from the literature, the present case of Cushing's disease exhibits characteristics suggesting a possible hypothalamic origin.
Similar articles
-
Failure of long-term therapy with sodium valproate in Cushing's disease.J Endocrinol Invest. 1997 Jul-Aug;20(7):387-92. doi: 10.1007/BF03347989. J Endocrinol Invest. 1997. PMID: 9309536
-
Five cases of cyclical Cushing's syndrome.Br Med J (Clin Res Ed). 1985 Nov 23;291(6507):1453-7. doi: 10.1136/bmj.291.6507.1453. Br Med J (Clin Res Ed). 1985. PMID: 2998540 Free PMC article.
-
A comparison of the use of urinary cortisol to creatinine ratios and nocturnal salivary cortisol in the evaluation of cyclicity in patients with Cushing's syndrome.J Clin Endocrinol Metab. 2013 Jan;98(1):E72-6. doi: 10.1210/jc.2012-2925. Epub 2012 Nov 12. J Clin Endocrinol Metab. 2013. PMID: 23150688
-
Drugs in the medical treatment of Cushing's syndrome.Expert Opin Emerg Drugs. 2009 Dec;14(4):661-71. doi: 10.1517/14728210903413522. Expert Opin Emerg Drugs. 2009. PMID: 19939210 Review.
-
[Diagnosis and differential diagnosis of Cushing's syndrome].Srp Arh Celok Lek. 2006 Nov-Dec;134(11-12):558-66. Srp Arh Celok Lek. 2006. PMID: 17304774 Review. Serbian.
Cited by
-
Molecular basis of pharmacological therapy in Cushing's disease.Endocrine. 2014 Jun;46(2):181-98. doi: 10.1007/s12020-013-0098-5. Epub 2013 Nov 23. Endocrine. 2014. PMID: 24272603 Review.
-
Pituitary disorders. Drug treatment options.Drugs. 2000 Jan;59(1):93-106. doi: 10.2165/00003495-200059010-00006. Drugs. 2000. PMID: 10718101 Review.
-
A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing's syndrome.BMC Endocr Disord. 2019 Oct 22;19(1):105. doi: 10.1186/s12902-019-0433-9. BMC Endocr Disord. 2019. PMID: 31640675 Free PMC article.
-
Failure of long-term therapy with sodium valproate in Cushing's disease.J Endocrinol Invest. 1997 Jul-Aug;20(7):387-92. doi: 10.1007/BF03347989. J Endocrinol Invest. 1997. PMID: 9309536
-
Cyclic Cushing's syndrome: an overview.Pituitary. 2004;7(4):203-7. doi: 10.1007/s11102-005-4025-5. Pituitary. 2004. PMID: 16132199 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical